News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) Has Credit Outlook Cut by Moody's


7/30/2013 7:18:51 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The ratings agency said the decision to change its view from stable was due to multi-billion-pound acquisitions, legal settlements over drugs and large share buybacks. Moody’s kept GSK’s A1 rating unchanged, but yesterday’s move raises the chance of a downgrade. While Moody’s “notes the ongoing investigation into GSK by China”, it added that this was “not a trigger for [Monday’s] action”.

Help employers find you! Check out all the jobs and post your resume.

Read at Telegraph
Read at Reuters
Read at NDTV.com


comments powered by Disqus
Telegraph
Reuters
NDTV.com
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES